Helicos Books $830K in First Instrument Revenue in Q1; Receives Commitments for Two More Placements

During the first quarter of 2009, Helicos recorded $829,000 in revenue from the sale of an instrument that it shipped in 2008, $134,000 from proprietary reagents sold to customers during Q1, and $239,000 from a National Institutes of Health grant.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.